University of California San Francisco
Give to UCSF
Two UCSF scientists – James Gardner, MD, PhD, and Rebeca de Pavia Fróes Rocha, PhD – have received Pew awards for their work in immunology as part of a program that supports promising early-career investigators.
Two new oral polio vaccines will help limit the amount of new polio strains and outbreaks by genetically engineering weakened polio virus in the oral vaccine to reduce reversion to dangerous forms.
Julia Adler-Milstein, PhD, has been appointed chief of the newly created Division of Clinical Informatics and Digital Transformation (DoC-IT) at UCSF. The new division will promote the integration and application of information technology to improve patient care.
As mental health needs rise in California, the UCSF Child & Adolescent Psychiatry Portal (CAPP) helps educate and train primary care physicians and pediatrics to provide support to patients with psychiatric needs.
Oncology specialists from around the globe will gather for the American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest cancer therapies, technologies, research and education.
Taking into account genetic factors that can change PSA levels not associated with cancer, the screening accuracy can be improved.
Face masks remain crucial in preventing the spread of COVID-19, even with vaccine availability. The decision to wear masks depends on vaccination status, risk factors, and local hospitalizations. Medical N95, KN95, or KF94 masks offer the best protection.
In a first, researchers have identified chronic pain pathways in individuals directly from their neural activity, showing promising paths forward for treatment.
UCSF faculty members Walter G. Gonzalez and Angela Phillips have been selected as Howard Hughes Medical Institute (HHMI) Freeman Hrabowski Scholars. With up to $8.6 million in support, they will conduct research, create inclusive lab environments, and make a significant impact on the future of science. Both scholars are committed to fostering diversity and promoting scientific breakthroughs.
COVID vaccine efficacy varied by age, BMI, sex, and smoking status, with levels changing over six months in a UCSF-led study. Pfizer and Moderna had higher antibody responses than Johnson & Johnson at one month, but Johnson & Johnson overtook them at six months.
Immunologist and UCSF Professor Emeritus Jeffrey Bluestone, PhD, has been elected to the National Academy of Sciences (NAS) – one of the highest honors bestowed on American scientists.
UCSF is the first hospital in California to offer pharmacogenetic testing for smarter prescribing. Testing identifies genetic makeup and tailors medications to improve efficacy and avoid lethal drug reactions.
From birth, Samantha has had four surgeries for heart disease. Her last surgery was aided by a 3D-printed replica of her heart, providing a detailed understanding of her heart’s anatomy. The surgery’s success allowed the now 15-year-old to lead a more normal life.
